Lpl Financial LLC Neurocrine Biosciences Inc Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Lpl Financial LLC holds 13,111 shares of NBIX stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,111

Previous 12,328 6.35%

Holding current value

$1.65 Million

Previous $1.7 Million 11.08%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$114.58 - $153.15 $89,716 - $119,916	783 Added 6.35%	13,111 $1.51 Million
Q2 2024 Aug 07, 2024	SELL	$130.86 - $143.19 $30,359 - $33,220	-232 Reduced 1.85%	12,328 $1.7 Million
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $356,383 - $392,841	2,733 Added 27.81%	12,560 $1.73 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $1,378 - $1,725	13 Added 0.13%	9,827 $1.29 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $150,432 - $187,360	1,600 Added 19.48%	9,814 $1.1 Million
Q2 2023 Jul 31, 2023	BUY	$89.53 - $104.87 $1,880 - $2,202	21 Added 0.26%	8,214 $774,000
Q1 2023 May 10, 2023	SELL	$94.11 - $123.02 $283,835 - $371,028	-3,016 Reduced 26.91%	8,193 $829,000
Q4 2022 Feb 07, 2023	SELL	$106.72 - $127.06 $456,548 - $543,562	-4,278 Reduced 27.62%	11,209 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $136,296 - $159,666	-1,481 Reduced 8.73%	15,487 $1.65 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $87,689 - $115,780	-1,157 Reduced 6.38%	16,968 $1.65 Million
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $94,040 - $123,063	-1,298 Reduced 6.68%	18,125 $1.7 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $110,235 - $147,008	-1,384 Reduced 6.65%	19,423 $1.65 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $572,579 - $657,955	6,644 Added 46.91%	20,807 $2 Million
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $684,497 - $782,774	7,654 Added 117.59%	14,163 $1.38 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $178,204 - $242,979	-2,035 Reduced 23.82%	6,509 $633,000
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $59,967 - $74,747	690 Added 8.79%	8,544 $819,000
Q3 2020 Nov 09, 2020	BUY	$96.16 - $135.15 $160,587 - $225,700	1,670 Added 27.01%	7,854 $755,000
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $32,844 - $50,318	386 Added 6.66%	6,184 $754,000
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $15,097 - $22,865	-201 Reduced 3.35%	5,798 $502,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $226,895 - $309,941	2,614 Added 77.22%	5,999 $645,000
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $18,188 - $22,025	-217 Reduced 6.02%	3,385 $305,000
Q2 2019 Aug 09, 2019	SELL	$72.24 - $91.27 $68,555 - $86,615	-949 Reduced 20.85%	3,602 $304,000
Q1 2019 May 08, 2019	BUY	$69.31 - $91.53 $45,536 - $60,135	657 Added 16.87%	4,551 $401,000
Q4 2018 Feb 07, 2019	BUY	$68.32 - $124.36 $266,038 - $484,257	3,894 New	3,894 $278,000

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Neurocrine Biosciences Inc Transaction History